No Easy Task But Insulet Determined To Fly Solo In Europe

After eight years together, Insulet will be splitting from its exclusive European distributor Ypsomed and take full responsibility for the distribution, sales, marketing, training and support activities of its Omnipod insulin management system in that region. Insulet's president and chief operating officer, Shacey Petrovic told Medtech Insight how the Massachusetts-based company will embark on this next solo chapter.

airport runway under the sun as background
Insulet to fly solo in 2018 with EU sales of Omnipod • Source: Shutterstock

The European health care market is not an easy one to navigate but insulin patch pump company Insulet Corp. is confident it will be able to tackle it on its own, following the decision to part ways with its exclusive European distributor of nearly eight years Ypsomed.

The two companies announced July 20 they will not be renewing their partnership, which started back in 2010, and that Insulet will take complete ownership of its Omnipod insulin patch...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Diabetic Care

More from Device Area